This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Rituximab infusion timing, cumulative dose, and hospitalization for COVID-19 in persons with multiple sclerosis in Sweden.
JAMA Network Open:2021: December 1 Full text
Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial.
JAMA:2021: December 7 Full text
Effect of PEP flute self-care versus usual care in early covid-19: non-drug, open label, randomised controlled trial in a Danish community setting.
BMJ:2021:375:e066952 Full text
Clinical Practice
Outcomes of rapid digital transformation of large-scale communications during the COVID-19 pandemic. AUS
Australian Health Review:2021: December 3 Full text
Trends in presentations to a private emergency department during the first and second waves of the COVID-19 pandemic in Australia. AUS
Australian Health Review:2021: December 3 Full text
Riding the waves: lessons learnt from Victoria’s COVID-19 pandemic response for maintaining effective allied health student education and clinical placements. AUS
Australian Health Review:2021: December 1 Full text
Pathophysiology and Epidemiology
Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes.
Clinical Kidney Journal:2021: November 27 Full text
Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for neuroscience.
Brain, Behavior & Immunity - Health:2021: November 30 Full text
COVID-19, hyperglycemia, and new-onset diabetes.
Diabetes Care:2021:44(12):2645-55 Full text
Prior glucose-lowering medication use and 30-Day outcomes among 64,892 veterans with diabetes and COVID-19.
Diabetes Care:2021:44(12):2708-13 Full text
Long Covid
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
Lancet:2021: November 10 Full text
Long COVID: the elephant in the room.
QJM:2021: November 26 Full text
Risk factors and incidence of Long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?
QJM:2021: November 26 Full text
Safety, feasibility, and outcomes of frequent, long-duration rehabilitation in an inpatient rehabilitation facility after prolonged hospitalization for severe COVID-19: an observational study.
Physical Therapy and Rehabilitation Journal:2021:101(11):pzab208 Full text
Infection Control
An upper bound on one-to-one exposure to infectious human respiratory particles.
Proceedings of the National Academy of Sciences:2021: December 7 Full text
Vaccines
BNT162b2 vaccine booster and mortality due to Covid-19.
New England Journal of Medicine:2021: December 8 Full text
Protection against Covid-19 by BNT162b2 booster across age groups.
New England Journal of Medicine:2021: December 8 Full text
Ad26.COV2.S or BNT162b2 boosting of BNT162b2 vaccinated individuals.
MedRxiv:2021: December 5 Full text
Odds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine.
JAMA Internal Medicine:2021: November 30 Full text
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals.
Science Translational Medicine:2021: December 7 Full text
Previous infection combined with vaccination produces neutralizing antibodies with potency against SARS-CoV-2 variants.
mBio:2021: December 7 Full text
Vaccine Adverse Effects
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines.
European Heart Journal: Quality of Care and Clinical Outcomes:2021: November 26 Full text
Immunology
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
Lancet Healthy Longevity:2021: December 1 Full text
